China Viva Biotech and HGL Pharma Form CRO Alliance

Viva Biotech, a Shanghai biologics-based CRO, has formed a CRO alliance with HGL Pharmaceuticals of Israel. Viva offers structure-based and fragment based drug discovery services while HQL has built a drug discovery CRO using its proprietary ChemSpace Scanner (CSS™) computational technology. Together, the two companies will offer leads generation based on fragment screening. More details.... Share this with colleagues: // //